Thus, our findings validate that activating PAX6 can impede glioma cell growth both in vitro and in vivo, with one mechanism inducing ferroptosis in glioma cells, suggesting that PAX6 could serve as a promising target for glioma. The gene discussed is PAX6; the disease is central nervous system cancer.